0002138500-26-000001.txt : 20260708 0002138500-26-000001.hdr.sgml : 20260708 20260708161325 ACCESSION NUMBER: 0002138500-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 EFFECTIVENESS DATE: 20260708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC CENTRAL INDEX KEY: 0002138500 ORGANIZATION NAME: EIN: 422747699 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590021 FILM NUMBER: 261162522 BUSINESS ADDRESS: STREET 1: 107 KILMAYNE DRIVE STREET 2: SUITE B CITY: CARY STATE: NC ZIP: 27511 BUSINESS PHONE: 9193356001 MAIL ADDRESS: STREET 1: 107 KILMAYNE DRIVE STREET 2: SUITE B CITY: CARY STATE: NC ZIP: 27511 D 1 primary_doc.xml X0708 D LIVE 0002138500 HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC 107 KILMAYNE DRIVE SUITE B CARY NC NORTH CAROLINA 27511 9193356001 DELAWARE None None Limited Liability Company true 2026 John Michael Harlow 744 Parkridge Drive Clayton NC NORTH CAROLINA 27527 Director Promoter Robert Earl Ross 107 Kilmayne Drive Suite B Cary NC NORTH CAROLINA 27511 Director Promoter John Powell Leachman 155 Piedmont Ave. Gainesville GA GEORGIA 30501 Director Promoter Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2026-06-29 false true false 5000 500000 265000 235000 false 14 0 0 0 false HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC John Michael Harlow John Michael Harlow Managing Director 2026-07-08